CVMA-ACMV

CVMA Presents on Antimicrobial Resistance at the House of Commons’ Standing Committee on Health

November 15, 2017

On November 9, 2017, Dr. Duane Landals, past president of the Canadian Veterinary Medical Association (CVMA) and current member of its Veterinary Pharmaceutical Stewardship Advisory Group, appeared on behalf of the association as a witness at the Standing Committee on Health as it conducts a study on antimicrobial resistance.
 
Dr. Landals highlighted the need for a One Health approach to develop strategies for responsible antimicrobial use that in turn supports the control of antimicrobial resistance.
 
CVMA highlighted its current initiatives on antimicrobial stewardship and antimicrobial surveillance, including the current collaboration with the Veterinary Drugs Directorate and other stakeholders to create common messaging to raise awareness of the rule changes Health Canada is implementing regarding the use of Medically Important Antimicrobials (MIAs) approved for veterinary use before 2004 to the Prescription Drug List (PDL). As of December 1, 2018, all MIAs for veterinary use will be on the PDL and must be sold by prescription only.
 
The CVMA emphasized the continued need to collaborate with various stakeholders to develop concrete ways to reduce the use of antimicrobials through prudent use.
 
  • View the full details of the meeting (meeting 78) here.
  • Find a copy of Dr. Landal's presentation to the Standing Committee here.
To stay up-to-date on Health Canada’s upcoming regulatory and policy changes, which strengthen veterinary oversight of antimicrobial use, visit the Veterinary Oversight of Antimicrobial Use in Canada section on our website.